Crusted Scabies in a Patient being Treated with Spesolimab for Generalized Pustular Psoriasis

Navarini AA, Burden AD, Capon F, Mrowietz U, Puig L, Köks S, et al. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol 2017; 31: 1792-1799.

https://doi.org/10.1111/jdv.14386 DOI: https://doi.org/10.1111/jdv.14386

Marrakchi S, Puig L. Pathophysiology of generalized pustular psoriasis. Am J Clin Dermatol 2022; 23: 13-19.

https://doi.org/10.1007/s40257-021-00655-y DOI: https://doi.org/10.1007/s40257-021-00655-y

Bachelez H, Barker J, Burden AD, Navarini AA, Krueger JG. Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion. Expert Rev Clin Immunol 2022; 18: 1033-1047.

https://doi.org/10.1080/1744666X.2022.2116003 DOI: https://doi.org/10.1080/1744666X.2022.2116003

Wolf P, Ceovic R, Conrad C, Falkensteiner K, Graier T, Kołt-Kamińska M, et al. Characteris-tics and management of generalized pustular psoriasis (GPP): Experience from the central and eastern Europe (CEE) GPP Expert Network. J Eur Acad Dermatol Venereol 2024; 38: 1531-1542.

https://doi.org/10.1111/jdv.19808 DOI: https://doi.org/10.1111/jdv.19808

Boehner A, Navarini AA, Eyerich K. Generalized pustular psoriasis - a model disease for specific targeted immunotherapy, systematic review. Exp Dermatol 2018; 27: 1067-1077.

https://doi.org/10.1111/exd.13699 DOI: https://doi.org/10.1111/exd.13699

Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, et al. Inhibition of the interleukin-36 pathway for the treatment of generalized pustular psoriasis. N Engl J Med 2019; 380: 981-983.

https://doi.org/10.1056/NEJMc1811317 DOI: https://doi.org/10.1056/NEJMc1811317

Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, et al. Trial of spesolimab for generalized pustular psoriasis. N Engl J Med 2021; 385: 2431-2440.

https://doi.org/10.1056/NEJMoa2111563 DOI: https://doi.org/10.1056/NEJMoa2111563

Blair HA. Spesolimab: First Approval. Drugs 2022; 82: 1681-1686.

https://doi.org/10.1007/s40265-022-01801-4 DOI: https://doi.org/10.1007/s40265-022-01801-4

Russo G, Dumont S, Menzinger S, Pastor D, Toutous Trellu L, Kaya G, et al. Severe acute generalized exanthematous pustulosis successfully treated by spesolimab. Acta Derm Venereol 2024; 104: adv41311.

https://doi.org/10.2340/actadv.v104.41311 DOI: https://doi.org/10.2340/actadv.v104.41311

Belvisi V, Orsi GB, Del Borgo C, Fabietti P, Ianari A, Albertoni F, et al. Large nosocomial outbreak associated with a Norwegian scabies index case undergoing TNF-α inhibitor treatment: management and control. Infect Control Hosp Epidemiol 2015; 36: 1358-1360.

https://doi.org/10.1017/ice.2015.188 DOI: https://doi.org/10.1017/ice.2015.188

Salavastru CM, Chosidow O, Boffa MJ, Janier M, Tiplica GS. European guideline for the management of scabies. J Eur Acad Dermatol Venereol 2017; 31: 1248-1253.

https://doi.org/10.1111/jdv.14351 DOI: https://doi.org/10.1111/jdv.14351

Alabbadi A, Alalwi S, Alkhalifah R, Alfaraj D, Albreiki S, Bin Rubaian N, et al. Scabies-associated leukocytoclastic vasculitis: A case report and review of literature. Cureus 2021; 13: e20725.

https://doi.org/10.7759/cureus.20725 DOI: https://doi.org/10.7759/cureus.20725

Chung SD, Lin HC, Wang KH. Increased risk of pemphigoid following scabies: a population-based matched-cohort study. J Eur Acad Dermatol Venereol 2014; 28: 558-564.

https://doi.org/10.1111/jdv.12132 DOI: https://doi.org/10.1111/jdv.12132

Pipitone MA, Adams B, Sheth A, Graham TB. Crusted scabies in a patient being treated with infliximab for juvenile rheumatoid arthritis. J Am Acad Dermatol 2005; 52: 719-720.

https://doi.org/10.1016/j.jaad.2004.12.039 DOI: https://doi.org/10.1016/j.jaad.2004.12.039

Saillard C, Darrieux L, Safa G. Crusted scabies complicates etanercept therapy in a patient with severe psoriasis. J Am Acad Dermatol 2013; 68: e138-e139.

https://doi.org/10.1016/j.jaad.2012.09.049 DOI: https://doi.org/10.1016/j.jaad.2012.09.049